#FutureReadyHealthcare

Who We AreInvestor RelationsNewsCareers
Indegene

Emerging Biotech

Develop and commercialize your product with an experienced partner

Redefine the innovation mindset

1,200
emerging biotech companies with products in phase 2 or phase 3
60%
molecules approved by FDA in next 5 years to come from emerging biotechs
62%
of recent product launches underperformed sales forecasts

Emerging biotech innovators are constrained by

Maximize your revenue potential with a growth-oriented partner

Prioritize development

Focus on building revenue and growing your brand with a custom-tailored, integrated solution across the product lifecycle

Retain ownership of your innovation

Retain control over your IP and revenue with a trusted partner to take your product to market successfully that scales as you grow

Access specialists on-demand

Optimize your business with ready access to a pool of industry and medical experts with institutional knowledge in your therapeutic area

What we do

Insights to build #FutureReadyHealthcare

Let’s partner for #FutureReadyHealthcare

© 2023 Indegene. All Rights Reserved.  

Privacy PolicyCSR PolicyIndegene Speak Up